In Jinxin Inc v Auletta & Ors [2026] EWHC 765 (Comm), the Commercial Court dismissed claims in deceit and conspiracy brought by the purchaser of a sports media rights business following its collapse. The decision provides important guidance on the scope of implied representations in commercial transactions, the role of contractual risk allocation mechanisms, and the evidentiary threshold for fraud claims.
It is of particular interest to parties involved in cross-border M&A, leveraged acquisitions, and the financing of such transactions.
Background
Jinxin Inc (Jinxin) was incorporated in February 2016 as a vehicle for two major Chinese corporate groups to acquire a 65% stake in the MPS Group, an international sports media rights business. The acquisition was completed in May 2016 at a price of US$715 million, pursuant to a Share Purchase Agreement governed by English law (the SPA). The MPS Group's business involved the acquisition and distribution of broadcasting and media rights across a range of sports, including Serie A Italian football and the FIFA World Cup. By 2018, the MPS Group had collapsed.
Jinxin brought claims in deceit and conspiracy against three defendants: Mr Riccardo Silva, the ultimate beneficial owner of one of the selling entities; Riccardo Silva Holding DAC (RSH), one of the sellers; and Mr Marco Auletta, the CEO of the MPS Group and also a seller. Jinxin alleged that false and fraudulent representations had been made to induce it to enter into the SPA across four categories: representations as to the absence of bribery and corruption in the business (Business Practices Representations); representations concerning the MPS Group's Serie A rights and the basis on which they had been secured (Serie A Representations); representations as to the scope of a criminal investigation in Milan involving Mr Silva (Investigation Representations); and representations as to the accuracy of EBITDA forecasts (EBITDA Representations). Jinxin alleged both express and implied representations within each category.
Notably, Jinxin did not pursue claims under the SPA’s warranty and indemnity regime but instead sought to construct its case entirely in tort, outside the contractual framework.
Decision
The Court dismissed all of Jinxin’s claims. The case raised a number of issues of broad commercial significance, addressed in turn below.
The tort of deceit
The Court applied the Privy Council's recent restatement of the law in Credit Suisse Life (Bermuda) Ltd v Ivanishvili [2025] UKPC, which confirmed that the tort of deceit requires: (1) a representation of fact or law, (2) which is false, (3) the maker does not believe to be true, (4) is intended to be believed by the representee, and (5) causes the representee to hold a false belief. A claimant must have suffered loss as a result of relying on the belief. A representation can be implied or express, and the Privy Council held that in the case of implied representations a claimant does not need to be consciously aware of the representation at the time they acted on it. The Privy Council observed that people frequently form and act on beliefs without any conscious awareness or thought. (See further discussion of this decision in our earlier article: Rethinking reliance in deceit claims.)
Express and implied representations
Jinxin's case relied heavily on both express and implied representations, which were alleged to arise from specific passages in the vendor documents (including a Business Plan, a Legal Vendor Due Diligence Report and a Financial Vendor Due Diligence Report) and their provision during the sale process. The implied representations were framed in sweeping terms, including that the business was honest, legal, and lawful, and that financial information was true and materially accurate. The Court’s treatment of each category of representation is addressed in turn below.
The SPA also contained a standard entire agreement clause under which each party acknowledged it had not relied on any pre-contractual representation or assurance. A fraud carve-out preserved liability for fraud. Equally, the SPA’s warranties were framed as warranties only, and not as “warranties and representations”, further limiting the scope for arguments based on extra-contractual assurances. The vendor documents each contained detailed disclaimers as to accuracy, completeness, and reliance.
The Business Practices Representations
As to the Business Practices Representations, the Court found that the passages relied upon by Jinxin, which addressed the absence of complaints, investigations, or proceedings relating to bribery and corruption, were directed to formal actions alleging such conduct, not a blanket assurance as to the honesty of the entire business. Understood in this way, the statements were not false. Even taking the representations as Jinxin framed them, the Court held that the payments and transactions at issue did not amount to bribery, corruption or similar misconduct, did not justify characterising the “business and business model” as dishonest, unlawful or illegal, and that the trial defendants were, at worst, mistaken but not dishonest. In any event, Jinxin did not rely on them, as they sought and obtained warranties in the terms found in the SPA in relation to matters that they wished to rely on.
The Serie A Representations
The Court found that the MPS Group’s success in securing Serie A rights was genuinely based on a long-standing relationship with the league, and that management’s confidence in renewal was honestly and reasonably held. While arrangements with competitors were capable of being anti-competitive, they did not amount to the knowingly unlawful “bid-rigging” alleged by Jinxin.
The Investigation Representations
The Court held that the information provided about the Milan criminal investigation was not forthcoming but was not dishonest, and that the documents did not carry the implied representations alleged. The Court also noted that Jinxin’s advisers flagged that the implications extended beyond what had been disclosed.
The EBITDA Representations
During the due diligence process, Jinxin’s own advisers had identified significant concerns with the reliability of MPS Group’s financial information and recommended that the EBITDA figures be treated with “significant caution”. The SPA included a bespoke price adjustment mechanism under which the purchase price would be adjusted if actual 2016 EBITDA fell below US$68 million.
On the EBITDA Representations, the Court held that the combination of the express disclaimers in the Business Plan which stated that projections were "preliminary and tentative only" and that no representation or warranty was made as to their accuracy, and the SPA's treatment of EBITDA, left no room for the implied representations alleged. The Court found that by the time of the SPA, Jinxin was not relying on the headline EBITDA figure of US$82.7 million but at most on a figure of US$68 million – below which it had contractually protected itself through the adjustment mechanism.
The Court rejected the argument for a broad principle that financial information provided in a commercial setting necessarily carries implied assurances of accuracy. Instead, information may be provided "as a step in the process of parties reaching a decision about what matters are to be relied upon", which the parties then formalise contractually.
Conspiracy
Jinxin also advanced a claim for unlawful means conspiracy, alleging that the trial defendants had combined to injure Jinxin by unlawful means through making the alleged representations. The conspiracy claim was dismissed as unsustainable, given the Court’s findings that no deceit had been established.
Key takeaways
This decision reinforces several important principles for parties involved in M&A transactions:
- Fraud claims require convincing evidence: While the standard of proof remains the balance of probabilities, allegations of fraud require convincing evidence. A business failing after acquisition, even if at a very substantial loss to the buyer, does not, in itself, establish that the sellers were dishonest or that the buyer was deceived.
- Implied representations face a high threshold: Courts will not readily imply sweeping representations such as that an entire business is “honest, legal and lawful” from the provision of vendor documents, particularly where express qualifications and disclaimers point the other way.
- Disclaimers and no-reliance language matter: Well-drafted disclaimers in information memoranda, business plans, and vendor due diligence reports can significantly limit the scope for implied representations as to accuracy and completeness, provided they are clear and prominent, particularly where the parties’ contract separately identifies the matters on which reliance is to be placed.
- Contractual risk allocation matters: Where a purchaser negotiates specific warranties, indemnities, and price adjustment mechanisms, these will be treated as the agreed framework for reliance. Attempts to argue parallel reliance on pre-contractual representations (particularly implied representations) face significant obstacles even where there is a fraud carve-out in non-reliance and whole agreement clauses.
- Buyer-side diligence is crucial: The quality of a purchaser’s own due diligence, and the advice received from its professional advisers, will be closely scrutinised. Concerns flagged by advisers that are then addressed contractually are powerful evidence against reliance by the purchaser on alleged representations by the seller.
With thanks to Alfie Holder for his assistance in preparing this post.
Subscribe to our Inside Disputes blog to receive regular expert insights into banking and commercial litigation in the English courts and issues relevant to investigations.